CSE: SONA | OTCQB: SNANF
+1-902-442-0653
Purdy’s Wharf Tower II Suite 2001 – 1969 Upper Water Street
Home
Science
Technology Overview
Targeted Hyperthermia Therapy
Scientific Evidence
Pipeline
Investors
Share Information
Investor Presentation
Research Coverage
Financial Reports
News & Media
News Releases
Carman’s Corner
Media Centre
Insights
About
Our Story
Leadership
Board of Directors
Advisory Board
Subscribe
Category:
News Releases
News & Media — News Releases
News Releases
May 1, 2025
Sona Nanotech Announces Annual Options Grants
March 19, 2025
Sona Presents Additional Preclinical Data Demonstrating Repeated Ability Of Its Cancer Therapy To Inhibit Tumor Growth In Colorectal Cancer Model
February 13, 2025
Sona Nanotech to Present Targeted Hyperthermia Therapy at the 19th International Canadian Melanoma Conference
January 16, 2025
Sona Nanotech’s THT Cancer Therapy Preclinical Efficacy Studies Published In Peer-reviewed Scientific Journal
December 11, 2024
Sona Nanotech’s THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study
November 7, 2024
Sona Nanotech to Showcase its THT Cancer Therapy at NCL 20th Anniversary Symposium and Provides Corporate Update
October 21, 2024
Sona Nanotech Issued Patent and Appoints New Board Member
October 9, 2024
Sona Nanotech Grants Options
September 24, 2024
Sona Nanotech Closes Private Placement Financing to Raise $1,643,750 in Gross Proceeds
September 5, 2024
Sona Nanotech Closes Private Placement Financing to Raise $1,500,000 in Gross Proceeds and Announces Additional Financing
Load More
Home
Science
Technology Overview
Targeted Hyperthermia Therapy
Scientific Evidence
Pipeline
Investors
Share Information
Investor Presentation
Research Coverage
Financial Reports
News & Media
News Releases
Carman’s Corner
Media Centre
Insights
About
Our Story
Leadership
Board of Directors
Advisory Board
Subscribe